Literature DB >> 33354122

Restless Legs Syndrome/Willis-Ekbom Disease in Multiple Sclerosis Patients with Spinal Cord Lesions.

Gülin SÜnter1, Özden KilinÇ1, Ahmet Berk1, Seyfullah AkÇabey1, Ekrem SaldÜz1, Hakan ÖztÜrkÇÜ1, Dilek İnce GÜnal1, Kadriye Agan1.   

Abstract

INTRODUCTION: Spinal cord lesions in Multiple Sclerosis (MS) patients are associated with a higher risk of restless legs syndrome (RLS). In this study, we investigated the prevalence of RLS, sleep quality, presence and severity of depression, and the relationship of these parameters with cervical cord lesions in patients with RRMS.
METHODS: This study was conducted in the outpatient multiple sclerosis clinic of Marmara University Hospital between October 2013 - February 2014, including 93 patients with the diagnosis of MS. After signing informed consent, demographic data, comorbidities and actual medication of the patients were collected. All patients completed the surveys including Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and Beck Depression Inventory (BDI). Prevalence of HBS, sleep quality and depression severity were compared between those with and without cervical cord lesions. Furthermore, the relationship between RLS and sleep quality, depression and expanded disability status scale (EDSS) was assessed.
RESULTS: From overall patients, 72% were women (n=67) and 28% (n=26) were men. From all subjects, 32% (n=30) fulfilled IRLSSG diagnostic criteria. Fifty-seven percent of the patients (n=53) had pathological spinal cord lesions. Patients with RLS had significantly higher prevalence of pathological spinal cord lesions compared to patients without RLS (p=0.04). Sleep quality was found to be poor in both patients with cervical cord lesions and patients with RLS and this was statistically significant (p=0.031, p=0.0001).
CONCLUSIONS: In summary, the possibility of RLS development in RRMS patients increases with the presence of lesions in spinal cord. Sleep quality was found to be poor in both patients with cervical cord lesions and patients with RLS. As RLS is a potentially treatable condition, increased awareness of diagnosis of RLS in MS patients may be important for early treatment and improve the comfort of the patient. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Restless leg syndrome/Willis-Ekbom disease; multiple sclerosis; spinal cord lesions

Year:  2019        PMID: 33354122      PMCID: PMC7735149          DOI: 10.29399/npa.23351

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  20 in total

1.  Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.

Authors:  W G Ondo; Y He; S Rajasekaran; W D Le
Journal:  Mov Disord       Date:  2000-01       Impact factor: 10.338

2.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

3.  Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study.

Authors:  Birgit Frauscher; Robert Egg; Elisabeth Brandauer; Hanno Ulmer; Thomas Berger; Werner Poewe; Birgit Högl
Journal:  Sleep Med       Date:  2005-08-05       Impact factor: 3.492

Review 4.  Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.

Authors:  Stefan Clemens; David Rye; Shawn Hochman
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

5.  Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study.

Authors:  J Vávrová; D Kemlink; K Sonka; E Havrdová; D Horáková; B Pardini; B Müller-Myhsok; J Winkelmann
Journal:  Sleep Med       Date:  2012-05-19       Impact factor: 3.492

6.  High prevalence of restless legs syndrome in multiple sclerosis.

Authors:  M Manconi; M Fabbrini; E Bonanni; M Filippi; M Rocca; L Murri; L Ferini-Strambi
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

7.  Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome.

Authors:  Shen Qu; Weidong Le; Xiong Zhang; Wenjie Xie; Aijun Zhang; William G Ondo
Journal:  J Neuropathol Exp Neurol       Date:  2007-05       Impact factor: 3.685

8.  Prevalence of sleep problems in individuals with multiple sclerosis.

Authors:  A M Bamer; K L Johnson; D Amtmann; G H Kraft
Journal:  Mult Scler       Date:  2008-07-16       Impact factor: 6.312

9.  Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis.

Authors:  M J Gómez-Choco; A Iranzo; Y Blanco; F Graus; J Santamaria; A Saiz
Journal:  Mult Scler       Date:  2007-03-15       Impact factor: 6.312

10.  Restless legs syndrome in multiple sclerosis: a case-control study.

Authors:  Marcello Deriu; Giovanni Cossu; Andrea Molari; Daniela Murgia; Alessandra Mereu; Paola Ferrigno; Davide Manca; Paolo Contu; Maurizio Melis
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

View more
  1 in total

Review 1.  Movement Disorders in Multiple Sclerosis: An Update.

Authors:  Ritwik Ghosh; Dipayan Roy; Souvik Dubey; Shambaditya Das; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.